Company / Inventory per Share
Biogen Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$14.96
FY2025
5-year range
$7.76 / $17.19
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
#4 of 108
Health Care
What the data says
Among 108 Health Care companies, Biogen is in the top 4% for inventory per share. Inventory per Share has fluctuated over the past 10 years, ranging from $3.80 in FY2019 to $17.19 in FY2023.
Based on SEC 10-K filings.
14.96 in FY2025 with a 5-year CAGR of +22.5%. Top quartile in the Health Care sector.
Declined from $17.19 to $14.96 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- +22.5%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 108This company $14.96 Sector average $30.00
▼
-50.1% below sector average
Key checks
Key Insights
- In FY2025, inventory per share decreased 12.4% year-over-year.
- Ranks #4 out of 108 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2023.
- Lowest inventory per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.96 | -12.4% |
| FY2024 | $17.09 | -0.6% |
| FY2023 | $17.19 | +94.9% |
| FY2022 | $8.82 | +13.7% |
| FY2021 | $7.76 | +43.2% |
| FY2020 | $5.42 | +42.5% |
| FY2019 | $3.80 | -11.7% |
| FY2018 | $4.31 | +3.0% |
| FY2017 | $4.18 | -8.7% |
| FY2016 | $4.58 | +20.3% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026